El desafío de las infecciones MDR y XDR 2025

Hospital Clínic de Barcelona.

Head of Section for immunosuppressed and severe bacteria at University Hospital Germans Trias i Pujol. Investigator Member of CIBERes and AGAUR.

Dr. Pedro-Botet is specialized in Infectious Diseases, Respiratory Infections and Legionella. She is currently Professor and Chair of Medicine and a member of the Grade of Medicine Committee at the Autonomous University of Barcelona’s School of Medicine. She has been Principal or co-Investigator of 10 projects funded either by national or international grant agencies. Author of 91 papers in peer-reviewed journals.

Head of Section for immunosuppressed and severe bacteria at University Hospital Germans Trias i Pujol. Investigator Member of CIBERes and AGAUR.

Dr. Pedro-Botet is specialized in Infectious Diseases, Respiratory Infections and Legionella. She is currently Professor and Chair of Medicine and a member of the Grade of Medicine Committee at the Autonomous University of Barcelona’s School of Medicine. She has been Principal or co-Investigator of 10 projects funded either by national or international grant agencies. Author of 91 papers in peer-reviewed journals.

Physician of the Infectious Diseases Department. Member of the Infection Control Team. Hospital Germans Trias i Pujol. Badalona. Barcelona Spain.

Associated Professor of Infectious Diseases. Faculty of  Medicine. Autonomous University of Barcelona

Investigator Member of CIBERes and AGAUR

Jesús Rodríguez Baño is a Professor in the Department of Medicine at the University of Seville, Head of the Infectious Diseases Department at the Virgen Macarena University Hospital in Seville, and Principal Investigator of the Clinical Research Group on Infectious Diseases at the Institute of Biomedicine of Seville. He is an Associate Editor of the journal Clinical Microbiology and Infection.

He has served as President of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), a member of the Scientific Committee of the Joint Programme Initiative on Antimicrobial Resistance (JPI-AMR) of the European Union, and is a consultant for the European Centre for Disease Control and Prevention (ECDC) on antimicrobial resistance.

His research focuses on the epidemiological and clinical aspects, as well as the treatment, of infections caused by resistant bacteria and the use of antimicrobials. He has been and continues to be the principal investigator of several national and European research projects, with 500 publications in scientific journals, a Web of Science H-index of 73, and recognition as a Highly Cited Researcher in 2023 and 2024.

Marta Hernández-Meneses is a specialist in Internal Medicine and Infectious Diseases. She completed her residency at Hospital Universitario Dr. Negrín (HUDNGC) and further specialized at Hospital Clínic de Barcelona, earning an International Ph.D. (UB, 2023). She holds three master’s degrees: HIV (UB, 2019), Applied Statistics in Health Sciences (UAB, 2019), and Infectious Diseases in Mobile Populations – International Health (UB, 2023). Her international training includes fellowships at Mayo Clinic (2019) and Brigham and Women’s Hospital – Harvard Medical School (2023), focusing on cardiovascular infections, mechanical circulatory support, cardiac and lung transplants, and ICU infections.
For the past eight years, she has been providing clinical care at the Infectious Diseases Department of Hospital Clínic de Barcelona focusing on critical care, cardiovascular infections, and infections in gynecology, obstetrics, and neonatology.
Her clinical and research work centers on cardiovascular infections, combining clinical studies with in vitro and in vivo models of biofilm and infective endocarditis. She has authored over 90 PubMed-indexed articles (H-index 23) and leads the PREDICT study on radiomics for diagnosing cardiovascular infections (AES-FIS 2024). Since 2020, she has been an associate professor at the University of Barcelona.

Pere-Joan Cardona serves as the Chief of the Microbiology Department at the “Germans Trias i Pujol” Hospital, which is part of the Catalan Institute of Health (ICS). He also holds the position of Professor at the Universitat Autònoma de Barcelona. With over 25 years of experience, he is a clinical microbiologist dedicated to unravelling the mechanisms underlying latent tuberculosis infection and the transition to active TB.
To advance his research efforts, Pere-Joan Cardona founded the Experimental Tuberculosis Unit at the Institute Germans Trias i Pujol (IGTP). His work has been instrumental in developing innovative “in vivo” and “in silico” experimental models, making substantial contributions to the field. Notably, his research resulted in the creation of the RUTI therapeutic vaccine and the exploration of host-directed therapies for tackling TB. Additionally, Pere-Joan Cardona has delved into the immunomodulatory properties of environmental mycobacteria, with the goal of harmonizing immune responses to combat various diseases.
Pere-Joan Cardona possesses extensive expertise in leading clinical trials aimed at developing novel diagnostic, prophylactic, and therapeutic tools for tuberculosis. His active collaboration with international consortiums dedicated to TB research underscores his dedication to advancing our understanding of this global health issue.
Once appointed as Chief of the Department, Pere-Joan Cardona has added some other interests in his focus. On one hand the use of NSG, for a molecular epidemiology program aimed to curtail the dissemination of M. tuberculosis clusters in Catalonia, that is funded and part of the Catalan Public Health Agency; the amplification of 16S for complex clinical samples and the characterization of the gut microbiota in different pathologies. He is also very interested in refining better tools for STD screening in general and high-risk populations. Finally, he is extending the experimental infection model in Drosophila to other pathogens, such us Enterococcus, Pseudomonas aeruginosa, Staphylococcus aureus and Candida albicans, to better understand the host-pathogen interface.

Specialist in infectious diseases, head of the Infectious Diseases Service and the Clinical Unit of Infectious Diseases and Microbiology at the Virgen del Rocío University Hospital in Seville. Leads the “Research Group on Bacterial Resistance and Antimicrobials. CIBERINFEC” at the Institute of Biomedicine of Seville (IBiS)/CSIC/University of Seville. Associate professor at the Faculty of Medicine, University of Seville. He has held key positions, such as president of the Andalusian Society of Infectious Diseases (2006-2007) and the Spanish Society of Infectious Diseases and Clinical Microbiology (2017-2019). He was medical director of the Virgen del Rocío University Hospital (2007-2009) and director of the PIRASOA program (2013-2021).